Shanghai Rongtai Health Technology (SHSE:603579) ROC (Joel Greenblatt) %: 16.15% (As of Jun. 2026) — 65% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603579 Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
70 GF Score
Price ¥17.61
GF Value ¥17.46
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Shanghai Rongtai Health Technology ROC (Joel Greenblatt) %?

Shanghai Rongtai Health Technology SHSE:603579 -2.33% 70 ROC (Joel Greenblatt) % is 16.15% as of Jun. 2026, which is 65% below its 10-year median of 45.73. GuruFocus rates SHSE:603579 with a GF Score™ of 70/100 and a GF Value™ of ¥17.46 (Fairly Valued). The stock has 6 warning signs investors should review. Among 847 Travel & Leisure companies, Shanghai Rongtai Health Technology ranks better than 56.55% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Shanghai Rongtai Health Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 16.15%.

The historical rank and industry rank for Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % or its related term are showing as below:

SHSE:603579' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 13.94   Med: 45.73   Max: 134.93
Current: 13.94

During the past 13 years, Shanghai Rongtai Health Technology's highest ROC (Joel Greenblatt) % was 134.93%. The lowest was 13.94%. And the median was 45.73%.

SHSE:603579's ROC (Joel Greenblatt) % is ranked better than
56.55% of 847 companies
in the Travel & Leisure industry
Industry Median: 10.61 vs SHSE:603579: 13.94

Shanghai Rongtai Health Technology's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -19.90% per year.


Shanghai Rongtai Health Technology  (SHSE:603579) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Shanghai Rongtai Health Technology ROC (Joel Greenblatt) % Related Terms


Shanghai Rongtai Health Technology ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Rongtai Health Technology ROC (Joel Greenblatt) % Chart

Shanghai Rongtai Health Technology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.68 28.36 29.36 20.96 14.76

Shanghai Rongtai Health Technology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.56 6.51 13.89 19.32 16.15

SHSE:603579 vs AS, HAS, LTH: ROC (Joel Greenblatt) % Comparison

For the Leisure subindustry, Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Rongtai Health Technology ROC (Joel Greenblatt) % vs Travel & Leisure Industry

For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % falls into.


SHSE:603579
70GF Score
Shanghai Rongtai Health Technology Corp Ltd SHSE:603579
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Rongtai Health Technology ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(213.232 + 219.306 + 651.044) - (509.709 + 0 + 26.91)
=546.963

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(255.193 + 212.213 + 343.793) - (565.774 + 0 + 38.266)
=207.159

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Shanghai Rongtai Health Technology for the quarter that ended in Jun. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=177.956/( ( (730.544 + max(546.963, 0)) + (719.514 + max(207.159, 0)) )/ 2 )
=177.956/( ( 1277.507 + 926.673 )/ 2 )
=177.956/1102.09
=16.15 %

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 16.15% mean?
Shanghai Rongtai Health Technology (SHSE:603579) has a ROC (Joel Greenblatt) % of 16.15% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 65% below median its historical median of 45.73. Over the past decade, Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % has ranged from 13.94 to 134.93. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #368 out of 847 companies in the Travel & Leisure industry, placing it in the top 43.4%.
Is Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % too high?
Shanghai Rongtai Health Technology's current ROC (Joel Greenblatt) % of 16.15% is 65% below median its 10-year median of 45.73. Over the past 10 years, this metric has ranged from a low of 13.94 to a high of 134.93. The Travel & Leisure industry median ROC (Joel Greenblatt) % is 10.61. Shanghai Rongtai Health Technology's value of 16.15% is 52.2% above this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #368 out of 847 companies in the Travel & Leisure industry, which is above the industry midpoint. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's ROC (Joel Greenblatt) % compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #368 out of 847 companies for ROC (Joel Greenblatt) %. This puts Shanghai Rongtai Health Technology in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 10.61. Shanghai Rongtai Health Technology's value of 16.15% is 52.2% above this benchmark. Historically, Shanghai Rongtai Health Technology's own ROC (Joel Greenblatt) % has ranged from 13.94 to 134.93 over the past decade. While the company's 10-year median is 45.73 vs. the industry median of 10.61, Shanghai Rongtai Health Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Travel & Leisure company?
The median ROC (Joel Greenblatt) % among Travel & Leisure companies is 10.61, based on 847 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current ROC (Joel Greenblatt) % of 16.15% is 52.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median ROC (Joel Greenblatt) % is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current ROC (Joel Greenblatt) % is 16.15%, which is 65% below median its own 10-year median of 45.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥17.46, compared to a current price of ¥17.61 — trading 0.9% above its estimated fair value. The current ROC (Joel Greenblatt) % is 16.15%, which is 65% below median its 10-year median of 45.73 and 52.2% above the Travel & Leisure industry median of 10.61. Shanghai Rongtai Health Technology's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current ROC (Joel Greenblatt) % is 16.15% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued. The current stock price of ¥17.61 is trading 0.9% above its estimated GF Value™ of ¥17.46. GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.

Key valuation signals for SHSE:603579:

  • ROC (Joel Greenblatt) %: 16.15% (65% below median its 10-year median of 45.73)
  • GF Value™: ¥17.46 vs. price of ¥17.61 (0.9% above fair value)
  • GF Score™: 70/100 with 6 warning signs
  • Industry Position: 52.2% above the Travel & Leisure median (#368 of 847)

No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Rongtai Health Technology Business Description

Address No. 1226 ZhuFeng Road, Qingpu District, Shanghai, CHN, 201702
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
70GF Score

Get the complete analysis for SHSE:603579

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.61
Price
¥17.46
GF Value